awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36219674-62C0AC2E-3DA9-4BA8-97AB-928BE4CC3594
Q36219674-62C0AC2E-3DA9-4BA8-97AB-928BE4CC3594
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36219674-62C0AC2E-3DA9-4BA8-97AB-928BE4CC3594
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML.
P2860
Q36219674-62C0AC2E-3DA9-4BA8-97AB-928BE4CC3594
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36219674-62C0AC2E-3DA9-4BA8-97AB-928BE4CC3594
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0dc04019fbf878c7db395be016dbc6172da677f5
P2860
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study